E-mail consults OK if paid Elderly breast cancer patients can skip radiotherapy Mother’s obesity affects oxygen transfer to fetus Out-of-office care improves outcomes for pregnant teens Multidisciplinary team sees reduction in C-section rates with weekly on-site program Panel nixes study of controversial MS treatment Patients with severe asthma benefit from omalizumab The monoclonal antibody omalizumab reduces the risk of exacerbations by about 25% over the course of a year among patients with more severe, persistent asthma. Report when MDs under drug investigation, CPSO urges police Second-line drug beats standard treatment in new cases of leukemia Side-effects force halt to monoclonal antibody trial Statins in primary prevention: The debate flares up Canadian dyslipidemia guidelines criticized for accepting results of ‘biased’ study Tattoos linked with greater hepatitis C risk The Healthcare Interview: Dr. Gabor Maté is on the addicts' side in the war on drugs The highly acclaimed physican writer weighs in on addiction and the war against drugs, and talks about his new book First Previous 1849 1850 1851 1852 1853 Next Last
